We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

HUBS:NYSEHubSpot, Inc. Analysis

Data as of 2026-05-22 - not real-time

$198.37

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

HubSpot delivered a robust 23.4% year‑over‑year revenue increase to $3.30 B, with an impressive 84% gross margin and a modest 3.3% operating margin, underscoring the scalability of its SaaS platform. Forward earnings per share of $15.61 translates to a forward P/E of about 12.7, a stark contrast to the trailing P/E of 104, indicating that earnings are expected to accelerate sharply. The discounted cash‑flow model values the stock at roughly $458, implying a potential upside of over 40% from the current price of $198. Technicals, however, are bearish: the price sits below the 20‑day, 50‑day, and 200‑day moving averages, the MACD histogram is negative, and the RSI hovers around 42, suggesting limited short‑term momentum. Volatility is elevated at nearly 90% over the past month, though the beta of 0.74 points to lower systematic risk relative to the market. The stock trades above its recent support of $173 but well below the $255 resistance, leaving a modest upside corridor in the near term. Increasing trading volume adds liquidity, but the sharp price decline of 71% over the past year reflects heightened investor sensitivity. The company’s cash position ($1.69 B) comfortably exceeds its debt ($0.25 B), and a debt‑to‑equity ratio of 12.4% signals a strong balance sheet. While no dividend is paid, the focus on reinvestment in AI‑driven features and expanding the CRM ecosystem supports long‑term growth prospects. Analyst consensus remains a “Buy” with a mean target of $280, reinforcing the valuation gap. In sum, the fundamentals and valuation suggest a compelling upside, but technical weakness and high volatility warrant caution in the immediate horizon.
Overall, HubSpot appears positioned for a rebound as earnings acceleration materializes, yet investors should monitor price action around the $200‑$210 range for confirmation before committing larger positions.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bearish technical indicators (price below SMAs, negative MACD)
  • Elevated short‑term volatility
  • Price near support level with limited immediate upside

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth and expanding SaaS addressable market
  • Forward earnings outlook and attractive forward P/E around 12.7
  • DCF‑derived upside of ~40% and analyst price targets above current level

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Strategic AI integration (Breeze) enhancing product differentiation
  • Solid cash generation and low leverage supporting reinvestment
  • Long‑term demand for integrated CRM and marketing automation solutions

Key Metrics & Analysis

Financial Health

Revenue Growth23.40%
Profit Margin3.04%
P/E Ratio104.4
ROE5.01%
ROA1.10%
Debt/Equity12.38
P/B Ratio5.2
Op. Cash Flow$798.0M
Free Cash Flow$656.2M
Industry P/E39.1

Technical Analysis

TrendBearish
RSI42.6
Support$173.25
Resistance$255.00
MA 20$214.16
MA 50$227.47
MA 200$350.69
MACDBearish
VolumeIncreasing
Fear & Greed Index91.5

Valuation

Fair Value$457.77
Target Price$280.16
Upside/Downside41.23%
GradeUndervalued
TypeGrowth

Risk Assessment

Beta0.74
Volatility89.65%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.